Cargando…
Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
Persistent pulmonary hypertension of the newborn (PPHN) is one of the diseases of the neonate with severe potential morbidity and mortality. Inhaled iloprost, a stable prostacyclin analog, has been suggested as an alternative treatment for inhaled nitric oxide (iNO). However, more data on neonates...
Autor principal: | Yıldırım, Şükran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352650/ https://www.ncbi.nlm.nih.gov/pubmed/37469523 http://dx.doi.org/10.1002/pul2.12268 |
Ejemplares similares
-
Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009) -
Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial
hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021) -
Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009) -
Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013) -
Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
por: Wang, Lan, et al.
Publicado: (2017)